Smoldering Acute Myelogenous Leukemia in the Elderly

References

• Rheingold J. J., Kaufman R., Adelson E., Lear A. Smouldering acute leukaemia. New England Journal of Medicine 1963; 268: 812–815
   PubMed Web of Science ®Google Scholar
• Bennett J., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French‐American‐British Cooperative Group. Annals of Internal Medicine 1985; 103: 626–629
   PubMed Web of Science ®Google Scholar
• Linman J. W., Bagby G. C. The preleukemic syndrome (hemopoietic dysplasis). Cancec 1978; 42: 854–864
   PubMed Web of Science ®Google Scholar
• Koeffler H. P., Golde D. W. Human preleukemia. Annals of Internal Medicine 1980; 93: 347–353
   PubMed Web of Science ®Google Scholar
• Weber R. F. A., Geraedts J. P. M., Kerkhofs H., Leeksma C. H. W. The preleukemic syndrome. I Clinical and hematological findings. Acta Medica Scandinavian 1980; 207: 391–395
   PubMed Web of Science ®Google Scholar
• Geary C. G. Clinical annotation. The diagnosis of preleukaemia. British Journal of Haematology 1983; 55: 1–6
   PubMed Web of Science ®Google Scholar
• Knospe W. H., Gregory G. A. Smoldering acute leukemia. Archives of Internal Medicine 1971; 127: 911–918
   Google Scholar
• Joseph A. S., Cinkotal K. I., Hunt L., Geary C. G. Natural history of smouldering leukaemia. British Journal of Cancer 1982; 46: 160–166
   PubMed Web of Science ®Google Scholar
• Van Slyck E. J., Rebuck J. W., Waddell C. C., Janakira‐man N. Smoldering acute granulocytic leukemia. Archives of Internal Medicine 1983; 143: 3740
   Google Scholar
• Broun G. O. Chronic erythromonocytic leukemia. American Journal of Medicine 1969; 47: 785–796
   PubMed Web of Science ®Google Scholar
• Zittoun R. Annotation: Subacute and chronic myelomonocytic leukaemia: A distinct haematological entity. British Journal of Haematology 1976; 32: 1–7
   PubMed Web of Science ®Google Scholar
• Beard M. E. J., Bateman C. J. T., Crowther D. C., Wrigley P. F. M., Whitehouse J. M. A., Fairley G., Scott R. Hypoplastic acute myelogenous leukaemia. British Journal of Haematology 1975; 31: 167–176
   PubMed Web of Science ®Google Scholar
• Needleman S. W., Bums C. P., Dick F. R., Armitage J. O. Hypoplastic acute leukemia. Cancel 1981; 48: 1410–1414
   PubMed Web of Science ®Google Scholar
• Howe R. B., Bloomfield C. D., McKenna R. W. Hypocellular acute leukemia. American Journal of Medicine 1982; 72: 391–395
   PubMed Web of Science ®Google Scholar
• Berdeaux D. H., Glasser L., Serokmann R., Moon T., Dune B. G. M. Hypoplastic acute leukemia: review of 70 cases with multivariate regression analysis. Hematological Oncology 1986; 4: 291–305
   PubMed Web of Science ®Google Scholar
• Greenberg P. L. The smoldering myeloid leukemic states: clinical and biologic features. Blood 1983; 61: 1035–1044
   PubMed Web of Science ®Google Scholar
• Tucker J., Thomas A. E., Gregory W., Ganesan T. S., Malik S. T. A., Amess J. A. L., Lim J., Willis L., Rohatiner A. Z. S., Lister T. A. Acute myeloid leukemia in elderly patients. Hematological Oncology 1990; 8: 13–21
   PubMed Web of Science ®Google Scholar
• Baudard M., Marie J. P., Cadiou M., Vigui B. F., Zittoun R. Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. British Journal of Haematology 1994; 86: 82–91
   PubMed Web of Science ®Google Scholar
• Marie J. P., Zittoun R., Thevenin D., Mathieu M., Vigui C. F. In vitro culture of clonogenic leukaemic cells in acute myelogenous leukaemia: growth pattern and drug sensitivity. British Journal of Haematology 1983; 55: 427–437
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Lowenberg B. Clonogenic cells in acute myelogenous leukemia. Blood 1986; 68: 1185–1195
   PubMed Web of Science ®Google Scholar
• Keating M. J., Cork A., Broach Y., Smith T., Walters R. S., McCredie K. B., Trujillo J., Freireich E. J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Research 1987; 11: 119–133
   PubMed Web of Science ®Google Scholar
• Schiffer C. A., Lee E. J., Tomiyasu T., Wiernik P. H., Testa J. R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263–270
   PubMed Web of Science ®Google Scholar
• Delmer A., Marie J. P., Thevenin D., Cadiou M., Viguie F., Zittoun R. Multivariate analysis of prognostic factors in acute myeloid leukemia: value of clonogenic leukemic cell properties. Journal of Clinical Oncology 1989; 7: 738–746
   PubMed Web of Science ®Google Scholar
• Raza A., Preisler H. D., Day R. H. S., Yasin Z. E., White M. J. H., Lykins J., Kiukla C., Barcos M., Bennett J., Browman G., Goldberg J., Grunwald H., Larson R., Vardi‐man J., Vogler W. R. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a Leukemia Intergroup study. Blood 1990; 76: 2191–2197
   PubMed Web of Science ®Google Scholar
• Löwenberg B., Van Putten W. L. J., Touw I. P., Delwel R., Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. New England Journal of Medicine 1993; 328: 614–619
   PubMed Web of Science ®Google Scholar
• Bennett J., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., French‐Amencan‐British Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Nüssler V., Sauer H., Pelka‐Fleischer R., Holzel D., Wilmanns W. Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia. European Journal of Haematology. 1990; 45: 19–25
   PubMed Web of Science ®Google Scholar
• Preisler H., Davis R., Kirshner J., Dupre E., Richards F., Hoagland H. C., Kopel S., Levy R. N., Carey R., Schulman P., Gottlieb A. J., McIntyre O. R., Cancer and Leukemia Goup B. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a Cancer and Leukemia Group B study. Blood 1987; 61: 1441–1449
   Google Scholar
• Copplestone J. A., Smith A. G., Osmond C., Oscier D. G., Hamblin T. J. Treatment of acute myeloid leukemia in the elderly: a clinical dilemma. Hematological Oncology 1989; 7: 53–59
   PubMed Web of Science ®Google Scholar
• Löwenberg B., Zittoun R., Kerkhofs H., Jehn U., Abels J., Debusscher L., Cauchie C. H., Peetermans M., Solbu G., Suciu S., Stryckmans P. On the value of intensive remission induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group. Journal of Clinical Oncology 1989; 7: 1268–1274
   PubMed Web of Science ®Google Scholar
• Löwenberg B., Fiere D., Zittoun R., Kerkhofs H., Stryckmans P., De Cataldo F., Tura S., Peetermans M., Paulus R., Goudsmit R., Sonnenveld P., Solbu G., Suciu S. Mitoxantron versus daunorubicin in induction of acute myelogenous leukaemia in elderly patients and low dose Ara‐C versus control as maintenance. An EORTC phase III trial (AML‐9). Haematologica 1991; 76(suppl 4), abstract 353
   Google Scholar
• Tilly H., Castaigne S., Bordessoule D., Casassus P., Le Pris B. P. Y., Tertian G., Desablens B., Henry‐Amar M., Degos L. Low‐dose Cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. Journal of Clinical Oncology 1990; 8: 272–279
   PubMed Web of Science ®Google Scholar
• Lazarus H. M., Vogler W. R., Burnus C. P., Winton E. F. High‐dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I‐II study of the Southeastern Cancer Study Group. Cancel 1991; 63: 1055–1059
   Web of Science ®Google Scholar
• Vogler W. R., Velez‐Garcia E., Weiner R. S., Flaum M. A., Bartolucci A. A., Omura G. A., Gerber M. C., Banks P. L. C. A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia; a Southeastern Cancer Study Group Study. Journal of Clinical Oncology 1992; 10: 1103–1111
   PubMed Web of Science ®Google Scholar
• Speer J. R., Freireich E. J., Hart J. S. Identification of smoldering leukemia by delaying chemotherapy (abstract). Proceeding (tenth) Annual Meeting of the American Society of Clinical Oncology 1974; 15: 73
   Google Scholar